key: cord-0068254-ni0j6s2t
authors: Cerqueti, Roy; Coppier, Raffaella; Girardi, Alessandro; Ventura, Marco
title: The sooner the better: lives saved by the lockdown during the COVID-19 outbreak. The case of Italy
date: 2021-09-03
journal: Econom J
DOI: 10.1093/ectj/utab027
sha: 2195f9f910bd84b288c34fbfca54a07bec7e4314
doc_id: 68254
cord_uid: ni0j6s2t

This paper estimates the effects of non-pharmaceutical interventions – mainly, the lockdown – on the COVID-19 mortality rate for the case of Italy, the first Western country to impose a national shelter-in-place order. We use a new estimator, the augmented synthetic control method (ASCM), that overcomes some limits of the standard synthetic control method (SCM). The results are twofold. From a methodological point of view, the ASCM outperforms the SCM in that the latter cannot select a valid donor set, assigning all the weights to only one country (Spain) while placing zero weights to all the remaining. From an empirical point of view, we find strong evidence of the effectiveness of non-pharmaceutical interventions in avoiding losses of human lives in Italy: conservative estimates indicate that the policy saved in total more than 21,000 human lives.

Exponentially growing threats require strong and early policy response. In the first wave of the COVID-19 outbreak, the timing of confinement measures played a fundamental role in flattening the contagion curve (Amuedo-Dorantes et al., 2021; Flaxman et al., 2020) . However, policy makers reasonably hesitate to take resolute measures when threats appear to be limited. This caution is reasonable, because, if countermeasures work, it will seem in retrospect as if the policy response was an overreaction, possibly causing a loss of consensus (The Economist, 2020; Pisano et al., 2020) . Once the curve is flattened, the public will likely blame the incumbent government for the tremendous economic losses caused by social distancing orders, without fully grasping their essential role in halting the spread of the viral disease.

This paper adds to this debate, estimating the effects of lockdown -or, in general, of the so-called non-pharmaceutical interventions -on the propagation of COVID-19 with particular emphasis on the most relevant aspect: saving human lives. Its real-world implications and its high level of socio-economic meaningfulness need no further explanation. The task is particularly challenging from a methodological perspective due to typical selection bias problems, and this explains the growing interest of econometricians in this research question. At first instance, a natural candidate to face this challenge is the standard synthetic control method (SCM), first introduced by Abadie and Gardeazabal (2003) and the subsequent studies by Abadie et al. (2010 Abadie et al. ( , 2015 . 1 At its very essence, the SCM involves the comparison of outcome variables between the treated unit, i.e., the unit affected by the intervention, and a combination of similar but different unaffected units. Such a comparison would reproduce an accurate counterfactual of the unit of interest in the absence of intervention, commonly referred to as the synthetic unit. This method can be conceived as a data-driven procedure to retrieve nontreated units sharing similar characteristics with respect to the treated in the pre-intervention period. In the COVID-19 context, the treatment consists of non-pharmaceutical interventions implemented at a given point in time in a specific country, so the SCM lends itself as one of the most immediate tools to face the problem empirically. For this reason, it has been (more or less successfully) repeatedly applied in the very recent literature on COVID-19. Bayat et al. (2020) and Friedson et al. (2020) have applied the SCM on U.S. data, where the latter takes a specific focus on California, taking advantage of the timely enactment of the shelter-in-place order. Friedson et al. (2020) extend the analysis of the impact to the unavoidable economic drawbacks, such as the number of jobs lost. As far as the measurement of the avoided virus spread is concerned, it is possible to mention Huber and Langen (2020) , who apply the SCM design to Switzerland, and Tian et al. (2020 Tian et al. ( , 2021 , who apply it to China. Some authors have estimated the effect of particular prescriptions included in the more general lockdown policy. Notably, Mitze et al. (2020) study the effect of wearing face masks in Germany and Neidhöfer and Neidhöfer (2020) study the effect of school closures for Argentina, Italy, and South Korea. Lee and Yang (2020) offer a purely economic perspective focusing on the impact of contrasting COVID-19 measures on the labour market in South Korea. As a peculiar case, Sweden is a country that has attracted a lot of attention in this growing literature because it is one of the very few countries that has not enacted a statewide shelter-in-place order (to date). Due to its unusual situation, Sweden offers the researcher an opportunity to look at the case as if the treatment consisted of nonintervention vis-a-vis a group of countries in which interventions took place (see Born et al., 2020, and Cho, 2020) . 1 Since its introduction, the SCM has been widely used in social sciences and applied to a broad spectrum of topics, spanning from terrorism and crime to natural resources and disasters, political and economic reforms, immigration, education, pregnancy and parental leave, taxation, as well as social connections and local development. Athey and Imbens (2017) have defined it as the most crucial innovation in the policy evaluation literature over the last fifteen years. For a recent survey see Abadie (2021) . Despite its popularity, however, some real-world circumstances can make this instrument unapplicable, under penalty of biased estimates. This occurrence may be due to many reasons, such as the employment of heterogeneous measurement methodologies whereby the same phenomenon is measured in different countries. The case under scrutiny falls exactly within these circumstances. To overcome this problem, we have followed a general approach proposed by Ben-Michael et al. (2021) , augmenting the SCM with the Ridge regression model, therefore obtaining a Ridge augmented synthetic control method (ASCM). To the best of our knowledge, the Ridge ASCM has not yet been applied to assess the impact of non-pharmaceutical interventions for the COVID-19 pandemic; it is possible to find just a couple of papers in the environmental field (notably, forest fires in Colombia, Amador-Jimenez et al., 2020, and air pollution in China, Cole et al., 2020) .

Our contribution to the literature on the socio-economic effects related to the COVID-19 pandemic is manifold. First, it sheds light on a controversial policy intervention that has been, and still is, widely debated. The intervention's effectiveness is evaluated in terms of the most immediate and desired effect, namely avoided deaths. Second, from a strictly methodological point of view, it uses one of the most recent advances of the popular SCM, i.e., the Ridge ASCM. This advance allows one to overcome the considerable limit of nonperfect pre-treatment fit, which, in turn, would generate a biased estimate from the canonical estimator. 2 Third, the study focuses on Italy, which is widely acknowledged as a paradigmatic case, owing to its pioneering role (immediately after China) in facing the current pandemic disease. The first Italian COVID-19 cases were registered quite early (January 2020 or even before) and contagion has accelerated since its inception. In March 2020, Italy was the country with the highest number of cases (apart from China) rapidly becoming the European epicentre of outbreak, with 207,428 confirmed cases and 28,236 deaths as of the beginning of May 2020 (Ministry of Health(2021). These figures represented approximately 14% of all confirmed cases and 20% of deaths in Europe, 6% of confirmed cases and just over 11% of deaths worldwide. Moreover, and even more interestingly from our standpoint, Italy was the first Western country in which the government imposed strict restrictions on mobility, economic activities, and social interactions. The lockdown order was officially imposed in Italy from 9 March to 18 May 2020, 70 seventy days. The intervention was highly criticized at that time, possibly because it was the first among Western countries, and the importance of timely acting was not completely clear yet; especially on the part of some media and politicians. Nonetheless, many other European countries followed the Italian model within a few weeks, including the UK, which had initially claimed to be against such a type of intervention. A long list of scientific contributions witnesses the relevance of the Italian case for understanding the COVID-19 spread and, consequently, the effectiveness of non-pharmaceutical interventions (see, e.g., Bonacini et al., 2020; Cameletti, 2020; Eckardt et al., 2020; Lolli et al., 2020; Palladino et al., 2020, Peracchi and Terlizzese, 2020) . In particular, the works by Modi et al. (2020) and Cerqua et al. (2020) deserve special mention because both use the standard SCM to assess the plausibility of official figures, concluding that the true count of deaths due to COVID-19 is supposed to be significantly higher than the official count.

Given the very high relevance of the issue at stake, we contribute to the debate over the effects of lockdown measures by using the Ridge ASCM, with all its methodological advances. To the best of our knowledge, this is the first paper to apply the Ridge ASCM to Italy's paradigmatic case and to evaluate the effects of a lockdown in terms of public health. Operatively, the task mentioned above is particularly challenging for at least a couple of other reasons. First, all the other European countries (the most similar to the one under scrutiny) were sooner or later treated also. Second, the virus spread followed different paths among countries at different points in time. Both features make constructing a credible counterfactual series particularly difficult, and this pitfall is exacerbated by the limits the standard SCM suffers from.

Our results show that the SCM cannot generate a valid counterfactual situation, collapsing all the weights on one single unit, i.e., Spain, so that the lockdown effect would be calculated as a naive difference between the two countries. Allowing for negative weights, we provide evidence about the effectiveness of non-pharmaceutical interventions in saving human lives and avoiding a collapse of the Italian health care system. The take-home message from this study is twofold. From a methodological point of view, it suggests that the researcher must compare the weights before choosing whether to apply the SCM or the ASCM. A substantial distance of the two may be an indirect indicator of bias in the SCM estimates. From a socio-economic perspective, it documents that non-pharmaceutical intervention led to around 21,600 lives saved over the first 35 days of lockdown.

The remainder of the paper is organized as follows. Section 2 introduces the Ridge ASCM as an extension of the canonical SCM and describes the dataset. Section 3 presents the empirical set-up, paying particular attention to how the benchmark specification is chosen. The main results obtained in Section 3 are put under test in Section 4. Finally, Section 5 proposes some back-of-the-envelope computations based on the estimates and draws some conclusions.

This section is devoted to the illustration of the Ridge ASCM procedure. To be self-contained and provide a better understanding of this econometric method, we begin with a brief description of the canonical SCM. In its very essence, the SCM aims to simulate the outcome path of a country if it did not undergo a particular policy intervention. Operatively, the synthetic control is built as a weighted average of the units in the control group (donor pool), where the weights are chosen so that the synthetic control's outcome closely matches the treated unit's trajectory in the pre-treatment period, while also satisfying some constraints such as being nonnegative or adding up to one.

More formally, let Y it (0) and Y it (1) represent the potential outcomes for unit i, with i = 1, . . . , N, at time t, with t = 1, . . . , T , under control and treatment, respectively. Let W i be an indicator that unit i is treated at time T 0 < T , where units with W i = 0 never receive the treatment. In the SCM, one supposes that only one unit receives treatment and for ease of reference this is listed as the first one, W 1 = 1, the remaining N 0 = N − 1 units are possible controls, usually referred to as donor units. Without loss of generality, for the time being, the post-treatment observation is limited to just one: T = T 0 + 1. The observed outcomes are then

We also assume that control potential outcomes are generated as a fixed component m it plus a mean-zero additive noise ε it drawn from some distribution,

It follows that the potential outcome under treatment can be written as Y it (1) = Y it (0) + τ it where τ it represent the treatment effects, which are the objects of our estimation, and are fixed parameters. Therefore, the treatment effects can be rewritten as

. The error terms in the post-treatment period are collected in the vector ε T = (ε 1T , . . . , ε NT ) and are assumed to be mean-zero and uncorrelated with treatment assignment. That is, the treatment assignment W i is ignorable given m it ,

where E ε T denotes the expectation taken with respect to the error term ε T . It follows that the noise terms for the treated and control units do not systematically deviate from each other. Let X it represent pre-treatment outcomes that are used as and along with other covariates, X 0 represents the N 0 × T 0 matrix of control units pre-treatment outcome and covariates. Y 0T is the N 0 vector of control unit outcomes in period T . With only one treated unit, Y 1T is a scalar, and X 1 is a T 0 -row vector of treated unit pre-treatment outcomes and/or covariates. The potential outcome for the treated unit, Y 1T (0), is computed by the SCM as a weighted average of the control outcomes, Y 0T γ , being γ = (γ 1 , . . . , γ N ) the vector of weights. The elements of γ are chosen to balance pre-treatment outcomes and other covariates. 3 To our aim, the SCM can be formalized as a solution with respect to γ of the following constrained optimization problem

where the constrains limit γ to the unit simplex and where

In the original formulation the hyperparameter ζ is set to zero and the simplex constraint in (2.4) ensures that the weights will be sparse and nonnegative. If we allow ζ to take positive values, we have a penalization of the dispersion of the weights, following a suggestion by Abadie et al. (2015) , and the optimization problem in (2.4) can be regarded as an approximate balancing weights estimator. These weights achieve perfect pre-treatment fit, and the resulting estimator has many attractive properties, including a bias bound derived by Abadie et al. (2010) , when the treated unit's vector of lagged outcomes and covariates, X 1 , is inside the convex hull of the control units' lagged outcomes and covariates, X 0 . Due to possible high dimension, however, achieving perfect pre-treatment fit is not always feasible with weights constrained to be on the simplex, and in these cases Abadie et al. (2015) recommend against using SCM. Thus, the conditional nature of the analysis is critical to deploying SCM, excluding many practical settings. This drawback is overcome by the Ridge ASCM of Ben-Michael et al. (2021) , which is now discussed.

Let Y iT (0) be the post-treatment control potential outcome andm 1T its estimator, the Ridge ASCM proposes modifying the problem in (2.4) as follows:

whereγ scm i is the estimated i-th SCM weight. In this context, the canonical SCM is a special case in whichm it is constant. Albeit fully equivalent, equations (2.5) and (2.6) help us to look at the Ridge ASCM from two different points of view. From the former equation, it is possible to see that the SCM estimate, i.e., the first term of (2.5), is corrected by the term in parenthesis, which captures the imbalance in the function of the pre-treatment outcomesm(.). The term in parenthesis can be regarded as an estimate of the bias generated by imbalance, not far from the correction for inexact matching. Therefore, the SCM and Ridge ASCM estimates will be similar if the estimated bias is small. As far as the latter equation is concerned, its formulation recalls the one of the standard doubly robust estimators (Robins et al., 1994) , which re-weights the outcome model to balance residuals. Given these premises, the choice of the estimatorm(.) is important both to understand the properties of the procedure and for practical performance. Notably, there are some attractive features of estimatingm(.) via Ridge regression which is linear in both pretreatment outcomes and in comparison units. This case is referred to as the Ridge ASCM. In this case, the estimator of the post-treatment outcome ism(X i ) =η ridge 0 + X iη ridge , whereη ridge 0 and η ridge are the coefficients of a Ridge regression of control post-treatment outcomes Y 0T on centred pre-treatment outcomes X 0 with penalty hyperparameter λ ridge :

The Ridge ASCM estimator is then:

when augmenting with Ridge regression, the implied weights are themselves the solution to a penalized synthetic control problem, as in the standard SCM problem. Nevertheless, while the original SCM constrains weights to be on the simplex, this does not occur with the Ridge ASCM. Indeed, when the treated unit lies outside the convex hull of the control units, the Ridge ASCM improves the pre-treatment fit relative to the SCM by allowing for negative weights and extrapolating away from the convex hull. The Ridge ASCM directly penalizes the distance from the sparse, nonnegative SCM weights, controlling the amount of extrapolation by the choice of λ ridge , and only resorts to negative weights if the treated unit is outside of the convex hull. When the treated unit is in the convex hull of the control units (so the SCM weights exactly balance the lagged outcomes) the Ridge ASCM and SCM weights are identical. When the SCM weights do not achieve an exact balance, the Ridge ASCM solution will use negative weights to extrapolate from the convex hull of the control units. The amount of extrapolation is determined both by the amount of imbalance and by the hyperparameter λ ridge . When SCM yields good pre-treatment fit or when λ ridge is large, the adjustment term will be small and γ aug will remain close to the SCM weights, Ridge ASCM and SCM weights will be equivalent and the estimation error will only be due to variance of the weights and post-treatment noise. It follows that λ ridge plays a crucial role and its value must be derived optimally. Operatively, one possibility is to follow the in-time placebo check proposed by Abadie et al. (2015) .

1T for some t ≤ T 0 as a placebo check. We can extend this idea to compute the leave-one-out cross validation mean squared error (MSE) over time periods:

(2.9) and the cross validation procedure chooses either the lambda that minimizes (2.9) or the maximal value of λ ridge with MSE within one standard deviation of the minimal MSE, as suggested by Hastie et al. (2009) , among others. Such a choice trades off overfitting, i.e., a too small λ ridge , and biased estimates, i.e., a too large λ ridge , indeed if λ ridge → ∞ ASCM is equivalent to SCM.

As mentioned above, the ASCM 4 procedure's goal is to evaluate the impact of a lockdown on the most immediate and desired effect, namely the number of avoided deaths. 5 Specifically, the outcome variable Y is the mortality rate, which is defined as the cumulative death counts per million population (dth) taken from the Epidemic Intelligence team of the ECDC (European Centre for Disease Prevention and Control 2020). Daily reported figures for deaths tend to be challenging to compare and qualify across countries due to possible confounding idiosyncratic socio-economic differences. For this reason, we also consider several covariates, X, among the predictors capturing the COVID-19 dynamics, such as cumulative cases per million population (num), which are intuitive predictors of mortality rates. The second group of predictors includes variables capturing the 'resilience' of each country's health system. This subset includes the number of hospital beds per hundred thousand population (hsp) under the assumption that the more developed the health system, the less fatal the COVID-19 infection will be. As for the outcome variable, the source for num and hsp is the Epidemic Intelligence team of the ECDC. Following Sá (2020) and Rocklöv and Sjödin (2020) , among others, we also include socio-economic characteristics that are likely to be (positively) related to mortality rates, i.e., the median age (age), as well as the average household size (hld). All demographic variables are taken from the United Nations report (United Nations, 2019). We also control for 'mobility trends' across different categories of places and behaviour changes derived from Google Mobility Reports, which collect percentage changes in visits and length of stay at different places relative to a baseline given by the median values of the same day of the week from 3 January 2020 to 6 February 2020. 6 Following Chernozhukov et al. (2021), we focus on four out of six mobility sub-indices (namely, 'Grocery and Pharmacy', 'Transit Stations', 'Retail and Recreation', and 'Workplaces'). 'Parks' and 'Residential' are dropped because the former does not have clear implications on the spread of COVID-19, and the latter shows an overlyhigh correlation with 'Workplaces' and 'Retail and Recreation'. We distil the information content conveyed by the mobility indicators into a synthetic index (mob) by following a 'nonmodel based' aggregation scheme, as discussed in Marcellino (2006) . 7 The subsequent logical step is identifying the donor states to form the synthetic control unit. The selection of the donor pool candidates should be carried out by identifying countries sharing some key similarities to the treated one. In the present context, geographical proximity is a crucial factor to be considered as the spread of the pandemic has been not homogeneous across space and over time; moving from Asia in late 2019 to Europe at the beginning of 2020 and subsequently to the Americas. Given our focus on the Italian case, an obvious choice to select the donor pool elements is to focus on European countries. Accordingly, we have included all members belonging to the European Union (except Luxembourg) plus Switzerland, Norway, and the United Kingdom (twenty-eight countries in total).

Since the daily evolution of the mortality rate at the individual country level reflects different diffusion patterns at a given point in time, we have normalized the time unit such that 'day 1' refers to the day on which cumulative infection cases per million exceeds one in the treated country, as in Cho (2020) . In our case, 'day 1' corresponds to 23 February 2020, with the lockdown policy enacted on 9 March. Therefore, in our setup, the pre-treatment period consists of 15 daily observations. Because the treated state contrasts to the control unit after treatment, the policy under scrutiny should not be enacted in any donor pool state during the study. Accordingly, our sample's ending date is given by the date when lockdown measures have taken place in the synthetic counterfactual. To identify such an average date, we have used an ad hoc index elaborated by the Oxford COVID-19 Government Response Tracker (2020), namely the Stringency Index (SI), which collects daily standardized information on several different common government responses for a large number of countries. More specifically, we have followed Cho (2020) and defined the ending sample as the date on which the SI peaked in each donor country. Therefore, our sample's last observation occurs on 'day 50', corresponding to 12 April 2020, so our posttreatment period consists of 35 data points.

As Figure 1 shows, the SI for Italy (dashed line) stands well above the average one for the donors (continuous line) over the entire sample span, especially in the pre-treatment period. Moreover, the ratios between individual countries' SI and the Italian index over the entire sample turn out to be well below the unity, suggesting that, on average, no donor country has implemented stronger lockdown policy than Italy over the temporal window covered by the analysis.

Resorting to the ASCM makes it possible to choose in a transparent way the weights to build the counterfactual for the treated unit (Abadie et al., 2010, p. 494) . Nonetheless, such an advantage is weakened by a lack of consensus on how (and what) covariates should be chosen. Due to the relative infancy of this approach, there are not enough papers to formally test for specification searching (Brodeur et al., 2016) . On the one hand, using all lagged outcome variables avoids the problem of omitting potentially irrelevant covariates. Indeed, this practice eliminates all other predictors' effects so that the synthetic counterfactual is created regardless of the other predictors' values (Kaul et al., 2021) . This specification is the one that minimizes the root mean squared prediction error (RMSPE) in the pre-treatment period, and that is not subject to arbitrary decisions. On the other hand, making all the other covariates irrelevant threatens the estimator unbiasedness in the post-treatment predictions (Ferman et al., 2020) . Given this lack of guidance, focusing on the specification that uses all the pre-treatment outcome lags as matching variables is generally recommended (Ferman et al., 2020) unless there is a strong prior belief that it is crucial to balance on a specific set of covariates (as in the present context). Moreover, optimizing the dependent variable pre-treatment fit and ignoring the covariates can be quite misleading. The more the covariates are truly influential for future values of the outcome, the larger a potential bias of the estimated treatment effect may become. 8 Therefore, economic theory and the researcher's intuition play a relevant part in the context of the ASCM as well.

Building on the relevant literature on the topic discussed in the Introduction, we have considered the following sets of covariates: variables related to the resilience of the health care system (captured by hsp), to the demographic structure of the population (represented by age and hld), as well as to the pandemic dynamics (epitomized by num and mob). Operatively, we first consider the specifications that differ only in the combinations of pre-treatment outcome values used as predictors. Specifically, we consider the following ones: (a0) all pre-treatment outcome values; (a1) odd pre-treatment outcome values only; (a2) even pre-treatment outcome values only; (a3) mean of all pre-treatment outcomes; (a4) the first half of the pre-treatment outcome values; (a5) the first three-quarters of the pre-treatment outcome values. We also consider a set of specifications from (a1) to (a5) where lagged dependent values as defined in (a1)-(a5) are augmented by structural time-invariant covariates (namely hsp, age, and hld). Finally, in the third group of specifications from (c1) to (c5), we extend the set of predictors by including time-varying predictors (namely, num and mob) averaged over the entire pre-treatment period.

As a preliminary step, we compute the average treatment effect on the treated (ATT) that is the average deviation of the counterfactual series from the actual one over the treatment period (from 9 March 2020 to 12 April 2020) for each specification (a0)-(c5) to identify the specifications with a negative and statistically significant gap in a way that is consistent with our priors. Since there is more than one possible specification that satisfies the conditions above, we follow the recommendation by Ferman et al. (2020) of presenting results for many different specifications, and, in particular, we include the specification (a0) as a benchmark. The upper part of Table 1 presents an overview of all the ASCM specifications that we consider in the analysis, while the last row reports the associated p-value for the computed ATT of the corresponding specification. 9 The results show that all of the ATTs are negative and statistically significant at the 5% level (or better), calling for a criterion to combine the test statistics for the individual specifications to distil them into a summary test statistic (Imbens and Rubin, 2015) . Expressly, we assume that the test function is simply a weighted average of the test statistics for individual specifications. The same equally-weighted scheme is applied to combine each specification into a synthetic statistic (Cohen- Cole et al., 2009; Christensen and Miguel, 2018) . In this vein, Figure 2 shows the treatment effects, defined as the differences between the mortality rate in Italy and the synthetic control over the evaluation period, averaged across all specifications (continuous black line), as well as the benchmark specification (a0) (dashed line). As expected, the mean value of the treatment effects suggests a strongly negative impact a few days after the intervention date. Moreover, there is preliminary evidence of statistical significance for these deviations from the actual path in the long-run, according to the confidence region computed as ±2.5 times the (median) absolute deviation from the median as suggested by Leys et al. (2013) .

While this finding gives indirect support to the effectiveness of non-pharmaceutical interventions in reducing the mortality rate, there is still a need for a criterion to select a given specification from a set of possible alternatives. It is well known that when covariates are expected to be useless in explaining the outcome, the recommended specification should use all pre-treatment outcome lags, i.e., specification (a0) (Kaul et al., 2021) . However, if the control unit should also match several socio-economically relevant covariates, attention should be paid to the specifications allowing external predictors. Since bs are a particular case of their corresponding c variants, we can safely restrict the focus on the latter group. A logical criterion to discriminate among the five remaining specifications with time-invariant and time-varying external predictors is given by each specification's lag structure. Since the pandemic dynamics are likely to affect the mortality rate with a temporal lag, specification (c3) is not the most desirable choice. Likewise, a lag structure based on either even or odd pre-treatment dates applied previously in SCM literature (see, e.g., Eren and Ozbeklik, 2016) is hard to rationalize in our context, suggesting that (c1) and (c2) are second-best options to alternative lag structures. This argumentation leads us to focus on the two remaining models: (c4) and (c5). In what follows, we pick (c4) as our preferred specification, while specification (c5) is used to check the robustness of our empirical findings. Accordingly, in our baseline model, the set of predictors includes time-invariant covariates, as well as the first half of the pre-treatment outcome values and time-varying covariates, averaged over the entire pre-treatment period. As Figure 3 shows, the gaps for our baseline specification closely resemble not only the one for specification (c5) but also the two summary statistics reported in Figure 2 . All in all, the temporal evolution of the treatment suggests a sort of delayed effect that becomes progressively negative as the days pass by. 

Although suggestive, the visual evidence presented above is insufficient to ensure proper implementation of the ASCM. Its practical use calls for the fulfillment of three conditions. For the first requirement, only the treated unit is affected by the policy change assessed over the post-treatment period (I). Secondly, the counterfactual outcome can be approximated by a fixed combination of donor states (II). Finally, the policy change has no effect before it is implemented (III). The procedures to align country-specific variables to a common starting date as well as the definition of a general rule to identify the (average) treatment date for the donor set (i.e., the last observation of our sample) discussed in Section 2.2 above help to answer point (I). As for point (II), Figure 4 reports the estimated weights according to both the ASCM and the canonical SCM for each country belonging to the donor pool. It emerges that the structure of the donor pool identified by the SCM consists of just one element (Spain) with weight zero attached to the remaining twenty-seven countries. In contrast, in the case of the ASCM, a richer structure of the weights emerges. The mortality rate is in line with Cho (2020) , who observes that death counts might be affected by measurement problems because some jurisdictions include both confirmed and probable cases of deaths, as opposed to others only reporting confirmed cases. In the specific case of Italy, Cerqua et al. (2020) claim that the official count of deaths due to COVID-19 is likely to under-report the phenomenon. The mechanics behind ASCM allow us to extrapolate out of the convex hull and to assign nonzero weights to a higher number of countries. In more detail, there is confirmation of a relevant role for Spain (0.909), along with France (0.718) and Poland (0.603), with (relatively smaller) positive weights attached to several other countries as well (namely, Belgium, Bulgaria, Denmark, Greece, the United Kingdom, the Netherlands, and Slovenia). In contrast, Germany, Switzerland, and Ireland do not contribute to the synthetic unit's construction, while the remaining 15 countries are associated with negative weights (ranging from −0.313 for Norway to −0.068 for Sweden). Overall, from an applied viewpoint, the ASCM can identify three European countries where the pandemic severity peaked compared to other donor pool candidate units. Simultaneously, resorting to the ASCM seems like a legitimate choice because of the documented difficulty to build up a donor pool by means of the canonical SCM. In such an occurrence, SCM and ASCM estimates tend to diverge. Specifically, ASCM estimates are likely to rely heavily on extrapolation from the convex hull of the control units in order to improve pre-treatment fit (Ben-Michael et al., 2021) by allowing for negative weights; whereas, the standard SCM imposes a sparse and always nonnegative weighting structure. 10 Turning to point (III), the synthetic outcome is expected to closely match the treated outcome's temporal profile during the pre-treatment period. Thus, as a preliminary step, Table 2 reports the average values over the pre-treatment period of the predictors for Italy (Actual) and the counterfactual control (Synth), where the latter is constructed with the ASCM weights. Overall, the synthetic control unit provides a much better-matched profile of Italy along the predictors, as compared to the simple average of all countries in the donor pool (Donor). This suggests that the ASCM-based selection of weights is more appropriate, rather than choosing the weights subjectively, for instance, by taking the simple average across all the donor units.

Such a requirement is necessary to ensure that the comparison of the outcome paths during the post-treatment period provides insight into the effect of the treatments. When the dynamics of the synthetic control and the treated entity tend to diverge, then the treatment presumably caused the difference. In contrast, if both paths display similarities in the treatment period, the treatment does not appear to have affected the outcome. Figure 5 compares the temporal profile of mortality rate for both actual and synthetic Italy by disentangling pre-and post-treatment periods. The upper panel assesses the quality of fit in the pre-treatment period and refers to the first 15 daily observations since the case per million exceeds one (corresponding to the temporal window from 23 February 2020 to 8 March 2020). The lower panel displays the difference of the two series over the entire sample span, which also includes the post-treatment period ranging from 9 March 2020 (when the policy intervention took place) to 12 April 2020.

While the cumulative mortality rate in the synthetic control unit closely overlaps the actual series prior to the pre-treatment period, there is a visible divergence a few days after the policy intervention date (vertical line in the lower panel) when the synthetic unit starts following a much steeper path than the actual counterpart series. The resulting gap, defined as the difference between the actual series and its synthetic control, turns out to be negative and statistically significant with an ATT of −135.2 and a p-value of 0.000. In more detail, we find that the cumulative mortality rate in synthetic Italy exceeds 683 per million population roughly five weeks after the lockdown intervention, while the corresponding figure for actual Italy is as low as 323. This evidence suggests that with a (negative) gap of around 360 deaths per million, Italy's mortality rate would have been higher by over 112% had there not been the policy intervention. Moreover, the gap from the actual series turns out to be statistically significant at the 95% level according to the confidence interval computed by the jackknife+ approach of Barber et al. (2019) .

Confidence intervals, as those reported in Figure 5 , have only recently been introduced (see also Cattaneo et al., 2019) in the SCM literature so that the statistical significance of the posttreatment gap is typically assessed by resorting to permutation techniques (the so-called placebo test; Abadie et al., 2010) . Nonetheless, permutation-based tests can convey useful information to support our empirical findings. In what follows, we discuss three types of sensitivity tests: placebo in-space, placebo in-time, and leave-one-out tests. Under the 'placebo in-space' test, the ASCM is sequentially applied to each country in the donor pool as though it is a treated state, using the remaining members of the pool as before.

The RMSPE measures the gap between the variable of interest for the treated country and its synthetic counterpart. It is possible to calculate a set of RMSPE values for the pre-and posttreatment periods for each unit considered in the analysis. Consequently, the RMSPE of the actual treated country after the treatment is expected to be large relative to its value before treatment. On the other hand, placebo units should not see a substantial increase in their RMSPE following the treatment. For this reason, Table 3 reports the RMSPE pre-and post-treatment ratio of each donor country divided by the same quantity computed for the treated country, Italy. Whenever the entry in the table is less than 1, this indicates a relatively higher difficulty when forecasting future outcome values for Italy. The share of RMSPEs above 1 is then used to obtain a p-value for Italy, which measures the probability of observing a ratio as high as the one obtained for Italy if one were to pick a country at random from the potential controls.

Overall, the RMSPE ratios turn out to be well below the unit threshold, suggesting that the actual path of the treated countries tends to diverge away from the synthetic control after the intervention in a much more substantial way than all countries belonging to the donor pool. The resulting p-value is (2/29=) 0.069 as it ranks second out of twenty-nine countries, which falls within the conventional range of statistical significance used in the relevant literature. A remarkable exception is Belgium's case, with an RMSPE slightly above the unit; nonetheless, the associated ATT has an opposite sign to the expected one in a way similar to what emerges for the other twelve countries. There is no evidence of a statistically significant ATT for three entities of the donor pool, while for the remaining cases, the estimated ATT ranges from −49.6 (for Norway) to 136.9 (for Belgium).

As a further sensitivity test, we run the 'in-time placebo' test, in which the donor pool remains fixed and the treated unit is always Italy, but the treatment date is re-assigned to occur during the pre-treatment period, as devised by Abadie et al. (2015) . Moreover, this placebo model's sample period must end when the actual treatment occurred (day 15, in our context) to avoid capturing its effects.

Operatively, the in-time placebo test is conducted under the assumption that the treatment occurred on day 8, roughly in the middle of our pre-treatment period. Apart from the lockdown date, we apply the baseline setup's exact setting to use the same predictor variables. As Figure 6 shows, our synthetic Italy for a placebo treatment on day 8 closely follows the path of actual Italy, not only during the first half of the baseline pre-treatment period but also in Notes: The column 'RMSPE ratio' reports the pre-and post-treatment RMSPE of each country of the donor pool relative to the same ratio for Italy. Whenever the entry is less than 1, the relative difficulty in forecasting future outcome values after intervention for Italy is higher than the 1 for the country considered. ATT = average treatment effect on the treated. the second part of the sample with an estimated gap barely different from zero (continuous black line) also according to the 95% confidence region. Similar results are obtained when the fictitious treatment date is assigned to days 10 and 12 (corresponding to two-thirds and three-quarters of the baseline pre-treatment period, respectively). According to the dotted and dashed lines in Figure 6 , significant reductions in the mortality rate for these two fake lockdown dates cannot be found over the actual pre-treatment period. Overall, the in-time placebo test assures that the placebo estimate resembles the actual pre-treatment path closely enough to give us confidence that our main findings are not through chance, ruling out the possibility that the above-discussed difference between the synthetic and actual Italy arises for reasons other than the treatment.

The third sensitivity check we consider is the leave-one-out test (Abadie et al., 2015) , where the model is iterated over to leave out one selected donor country each time to assess whether one of the donor units is driving the results. Figure 7 shows all leave-one-out synthetic gaps (thin grey Figure 6 . In-time placebo. Notes: The horizontal axis indicates the days after the death per million exceeds one. The black solid, dotted, and dashed lines are the gap plot when the fictitious treatment date is assigned to half, two-thirds and three-quarters of the actual pre-treatment period, respectively. The shaded area is the 95% confidence interval computed by means of the jackknife+ approach of Barber et al. (2019) .

lines) and the mean value across all of them (dashed line). It emerges that the average gap across all permutations closely matches the baseline gap that includes all donor states in terms of ATTs (−135.1 and −135.2, respectively), giving further support to the robustness of our findings. Finally, the sharp decrease in deaths caused by the lockdown occurs because social interactions are banned and, consecutively, infection cases decrease. These two intermediate outcomes, social interactions, and the number of cases act as mediators. Figure 8 presents the gap plot of the weekly measure of Google mobility trend, panel (a), and of cases per million population, panel (b). Both outcomes present a negative gap since the lockdown inception, consistent with the drift of cumulative deaths per million population. This provides evidence of the channels through which the lockdown operates.

This paper is the first contribution that uses the ASCM to evaluate the effectiveness of nonpharmaceutical interventions against COVID-19. Evidence has been provided for Italy, the first Western country that implemented shelter-in-place orders after China.

The paper shows how the ASCM helps to remove bias from a naive application of the canonical SCM. Indeed, the latter estimator shrinks the donor pool to only one country, i.e., Spain, generating de facto an estimate of the effect as a bare difference between Italy and Spain. Constraining SCM weights on the unit simplex may be too restrictive, especially when it is hard to reproduce accurate synthetic pre-treatment dynamics. Our empirical case falls precisely in this circumstance, and the ASCM overcomes the problem by assigning negative weights to some donor units. As already pointed out by Ben-Michael et al. (2021) , since the ASCM removes the nonnegativity constraint and allows for extrapolation outside of the convex hull, the pre-treatment fit from ASCM turns out to be at least as good as the pre-treatment fit from the SCM alone. Our evidence suggests that applied economists should compare weights obtained from the SCM and the ASCM and opt for the former only if the two are not entirely different. The socio-economic relevance of the issue analysed in this contribution makes the importance of such a comparison even more evident because the estimates may significantly diverge, and different conclusions may be based on biased estimates. The results report extensive evidence on the effectiveness of non-pharmaceutical interventions in avoiding human deaths and preventing health care systems from collapsing in the present COVID-19 era. According to our benchmark estimate, for each life lost, the policy has saved 1.12 lives. In other words, while the cumulative mortality rate has recorded 323 lives lost per million population, without lockdown policy, it would have been 683, that is 360 lives saved per million population. With 60 million as the 2020 Italian population in total, the policy has produced (60 × 360=) 21,600 lives saved. It is important to stress that this figure can be considered conservative because the sample span we can use for the econometric exercise is shorter than the total temporal horizon over which the policy has been implemented, due to the lack of nontreated units from a specific point in time onwards. Similar desirable results, albeit not comparable in magnitude, have been found by Friedson et al. (2020) for California, while for the case of Sweden, Cho (2020) estimates that 25% of lives lost are attributable to the nontreatment decision. Due to limited external validity and different methodologies applied, the figure by Cho (2020) is scantly comparable with ours. Nevertheless, a more substantial effect in Italy is quite reasonable because of structural differences between the two countries in terms of (lower) endowment of hospital beds, (older) median age of the population and (larger) household average size (for Italy). As a possible extension, one could think of extending and projecting the findings up to the last day of the policy (i.e., another thirty-six extra days up to 18 May 2020) and re-calculate the total effect of the policy. One can also consider relating the findings of this paper to economic damages caused by the lockdown measures. Whereas, from a strictly methodological point of view, a further possible extension consists in constructing a formal test to test the equality of the weights generated by the SCM and the ASCM, these issues are beyond the scope of the present work and are left for further research.

Using synthetic controls: Feasibility, data requirements, and methodological aspects

Synthetic control methods for comparative case studies: Estimating the effect of California's tobacco control program

Comparative politics and the synthetic control method

The economic costs of conflict: A case study of the Basque Country

A penalized synthetic control estimator for disaggregated data

The unintended impact of Colombia's COVID-19 lockdown on forest fires

mRSC: Multidimensional robust synthetic control

Robust synthetic control

Early adoption of nonpharmaceutical interventions and COVID-19 mortality

Synthetic difference in differences

The state of applied econometrics: Causality and policy evaluation

Approximate residual balancing: Debiased inference of average treatment effects in high dimensions

Predictive inference with the jackknife

Synthetic control, synthetic interventions, and COVID-19 spread: Exploring the impact of lockdown measures and herd immunity

The augmented synthetic control method

Identifying policy challenges of COVID-19 in hardly reliable data and judging the success of lockdown measures

The lockdown effect: A counterfactual for Sweden

On the role of covariates in the synthetic control method

Star wars: The empirics strike back

The effect of corona virus lockdown on air pollution: Evidence from the city of Brescia in Lombardia region (Italy)

Prediction intervals for synthetic control methods

Local mortality estimates during the COVID-19 pandemic in Italy

Causal impact of masks, policies, behavior on early covid-19 pandemic in the

A t-test for synthetic controls

An exact and robust conformal inference method for counterfactual and synthetic controls

Quantifying the impact of non-pharmaceutical interventions during the COVID-19 outbreak: The case of Sweden

Transparency, reproducibility, and the credibility of economics research

Model uncertainty and the deterrent effect of capital punishment

The impact of the Wuhan COVID-19 lockdown on air pollution and health: A machine learning and augmented synthetic control approach

Pooling multiple case studies using synthetic controls: An application to minimum wage policies

COVID-19 across European regions: The role of border controls

What do right-to-work laws do? Evidence from a synthetic control method analysis

European Centre for Disease Prevention and Control (ECDC)(2020), Epidemic Intelligence Team

Cherry picking with synthetic controls

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

Did California's shelter-in-place order work? Early coronavirus-related public health effects

Google Mobility Report

The Elements of Statistical Learning. Springer series in statistics

The impact of response measures on COVID-19-related hospitalization and death rates in Germany and Switzerland

Causal Inference for Statistics, Social, and Biomedical Sciences: An Introduction

Standard Synthetic Control Methods: The Case Of Using All Preintervention Outcomes Together With Covariates

Pandemic and employment: Evidence from COVID-19 in South Korea

Detecting outliers: Do not use standard deviation around the mean, use absolute deviation around the median

Impact of meteorological conditions and air pollution on COVID-19 pandemic transmission in Italy

Leading indicators

Monitoraggio Covid-19

Face masks considerably reduce COVID-19 cases in Germany: A synthetic control method approach

Total COVID-19 mortality in Italy: Excess mortality and age dependence through time-series analysis

The effectiveness of school closures and other pre-lockdown COVID-19 mitigation strategies in Argentina, Italy, and South Korea. ZEW-Centre for European Economic Research Discussion Paper

Excess deaths and hospital admissions for COVID-19 due to a late implementation of the lockdown in Italy

Estimating the prevalence of the COVID-19 infection

Imperfect synthetic controls: Did the Massachusetts health care reform save lives

A framework for synthetic control methods with highdimensional, micro-level data: Evaluating a neighborhood-specific crime intervention

Estimation of regression coefficients when some regressors are not always observed

High population density catalyse the spread of COVID-19

Socioeconomic determinants of COVID-19 infections and mortality: Evidence from England and Wales

How to build social consensus around lockdown

The effects of stringent interventions for coronavirus pandemic

The timing and effectiveness of implementing mild interventions of COVID-19 in large industrial cities

Patterns and trends in household size and composition: evidence from a United Nations dataset